Tolerion

Developer of therapeutics to treat autoimmune diseases

placeSan Francisco, California, United States calendar_todayFounded 2001 groups12 employees language tolerion.bio

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon